I$\text{'}$m sending this again because it was wrong the first time.

The following transactions have also occurred at Skysong.

$1.$ Options were granted on July $1,2024,$ to purchase $200,000$ shares at $\backslash (\backslash$$ $15\backslash )$ per share. Although no options were exercised during fiscal year $2025,$ the average price per common share during fiscal year $2025$ was $\backslash (\backslash$$ $20\backslash )$ per share.

$2.$ Each bond was issued at face value. The $\backslash (9\backslash \%\backslash )$ convertible bonds will convert into common stock at $50$ shares per $\backslash (\backslash$$ $1,000\backslash )$ bond. The bonds are exercisable after $5$ years and were issued in fiscal year $2024.$

$3.$ The preferred stock was issued in $2024.$

$4.$ There are no preferred dividends in arrears; however, preferred dividends were not declared in fiscal year $2025.$

$5.$ The $\backslash (1,020,000\backslash )$ shares of common stock were outstanding for the entire $2025$ fiscal year.

$6.$ Net income for fiscal year $2025$ was $\backslash (\backslash$$ $1,480,000\backslash ),$ and the average income tax rate is $\backslash (20\backslash \%\backslash ).$

For the fiscal year ended June $30,2025,$ calculate the following for Skysong Pharmaceutical Industries. $($Round answers to $2$ decimal places, e$.$g$.2\mathrm{.}45.)$

a$.$ Basic earnings per share.

Basic earnings per share $\backslash$$

b$.$ Diluted earnings per share.

Diluted earnings per share $\backslash (\backslash$$ $\backslash )$ Amy Dyken, controller at Skysong Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Skysong's financial statements. Below is selected financial information for the fiscal year ended June $30,2025.$

Skysong Pharmaceutical Industries

Long$-$term debt

Notes payable, $10\backslash \%$

$\backslash$$$1,010,000$

$9\backslash \%$ convertible bonds payable

$4,930,000$

$\backslash (10\backslash \%\backslash )$ bonds payable

Total long$-$term debt

Shareholders' equity

Preferred stock, $6\backslash \%$ cumulative, $\backslash$$$50$ par value, $106,000$ shares authorized, $26,500$ shares issued and outstanding

Common stock, $\backslash (\backslash$$ $1\backslash )$ par, $10,200,000$ shares authorized, $1,020,000$ shares issued and outstanding

$\backslash$$$1,325,000$